PM2ch36.pdf

(865 KB) Pobierz
Military Preventive Medicine: Mobilization and Deployment, Vol 2 Chapter 36 Diseases Transmitted Primarily from Animals to Humans
Diseases Transmitted Primarily from Animals to Humans
Chapter 36
DISEASES TRANSMITTED PRIMARILY
FROM ANIMALS TO HUMANS
PATRICK W. KELLEY, MD, DRPH
KELLY T. MCKEE, JR., MD, MPH
KENT E. KESTER, MD
WILLIAM R. BYRNE, MD
CLIFTON A. HAWKES, MD
CHRISTIAN F. OCKENHOUSE MD, P H D
ARTHUR M. FRIEDLANDER, MD
LISA A. PEARSE, MD, MPH
JULIE PAVLIN, MD, MPH
COLONEL DAVID HOOVER, MD
LEPTOSPIROSIS
HANTAVIRUSES
TOXOPLAMOSIS
Q FEVER
VIRAL HEMORRHAGIC FEVERS
RABIES
TULAREMIA
ANTHRAX
BRUCELLOSIS
937
 
Military Preventive Medicine: Mobilization and Deployment, Volume 2
P. W. Kelley ; Colonel, Medical Corps, US Army (Retired); Director, Board on Global Health, Institute of Medicine, 500 Fifth Street,
NW, Washington, DC 20001; Formerly, Director, Division of Preventive Medicine, Walter Reed Army Institute of Research, Direc-
tor, DoD Global Emerging Infections System, Silver Spring, MD 20910-7500
K.T. McKee, Jr. , Colonel, Medical Corps US Army (Retired); Director of Extramural Clinical Research, US Army Medical Research
Institute of Infectious Diseases,1425 Porter Street, Fort Detrick, MD 21702; Formerly, Chief, Medical Operations Division, US
Army Medical Research Institute of Infectious Diseases
K.E. Kester , MD, Lieutenant Colonel, Medical Corps, US Army; Chief, Department of Clinical Trials, Division of Communicable
Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, MD 20910-7500
W.R. Byrne , MD, Colonel, Medical Corps US Army; Infectious Disease Officer, Infectious Disease Service, Walter Reed Army Medi-
cal Center, Washington, DC 20307-5001; Formerly, Chief, Medical Division, United States Army Medical Research Institute of
Infectious Diseases, Fort Detrick, MD 21702-5011
C.A. Hawkes , MD, Colonel, Medical Corps, US Army; Chief, Infectious Disease Service, Walter Reed Army Medical Center, Wash-
ington, DC 20307-5001
C.F. Ockenhouse MD, PhD, Colonel, Medical Corps, US Army; Infectious Disease Officer, Department of Immunology, Division of
Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910-7500
A.M. Friedlander , MD, Colonel, Medical Corps, US Army (Retired); Senior Military Scientist, US Army Medical Research Institute
of Infectious Diseases, Fort Detrick, MD 21702-5011; Adjunct Professor of Medicine, Uniformed Services University of the Health
Sciences, 4301 Jones Bridge Road, Bethesda, Maryland 20814-4799
L.A. Pearse , MD, MPH, Major, Medical Corps, US Army; Chief, Mortality Surveillance Division, Armed Forces Institute of Pathol-
ogy, 1413 Research Boulevard, Building 102, Rockville, MD 20850; Formerly, Chief, Preventive Medicine Service, William Beau-
mont Army Medical Center, El Paso, TX 79920-5001
J. Pavlin , MD, MPH, Lieutenant Colonel, Medical Corps, US Army; Chief, Department of Field Studies, Walter Reed Army Institute
of Research, Silver Spring, MD 20910-7500
D. Hoover , MD, Colonel, Medical Corps, US Army; Infectious Disease Officer, Department of Bacterial Diseases, Division of Com-
municable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, MD 20910-7500
938
Diseases Transmitted Primarily from Animals to Humans
LEPTOSPIROSIS
Introduction and Military Relevance
Center in Panama, 42% had leptospira in their urine
(Takafuji ET. 1982. Unpublished data). Even dogs
immunized to prevent clinical disease can develop
renal shedding. 4 In the environment, L interrogans
can survive under favorable conditions for as long as
6 months. Tropical, unpolluted, nonsaline, slightly
alkaline waters provide an ideal environment.
Although leptospires usually enter the person
through breaks in skin or mucous membranes, pro-
longed immersion in water may facilitate infection
through otherwise intact skin. Service members
seem to be at particular risk during operations in
swamps, streams, ponds, and muddy areas. Lep-
tospirosis has been particularly noteworthy among
US forces operating in Panama and Vietnam. 1,2
Other professions that are notably at risk include
agriculture and aquaculture, sewer and construc-
tion work, animal husbandry, veterinary and
slaughterhouse work, mining, and laboratory work.
Increasingly, recreational pursuits have been shown
to be correlated with risk; this includes care of pets,
hunting, fishing, swimming in ponds and other
bodies of fresh water, rafting, and playing sports
on muddy fields. 5–7 Other possible routes of infec-
tion implicated include contaminated drinking
water and food preparation surfaces, and, rarely,
animal bites. Extremely rare routes of transmission
include human-to-human transmission through
urine, breast milk, and sex. 8,9
Leptospirosis is a zoonotic infection in which
humans are incidentally infected when they have
direct or indirect skin or mucous membrane con-
tact with the contaminated urine of infected wild
and domestic animals. Leptospirosis has been well
documented in military populations with a history
of exposures to mud or various bodies of water in
endemic locales. 1,2 It is caused by a spirochete, and
transmission can occur in urban, suburban, and
rural settings in both tropical and temperate areas.
The clinical spectrum ranges from an asymptom-
atic or influenza-like infection (the most common
presentation) through hemorrhagic manifestations,
meningismus, jaundice, and renal failure. The more
severe end of the spectrum is called Weil’s syn-
drome. Although efforts at prevention can include
immunization of domestic animals, the major
means of prevention used in the military setting
include education, rodent control, and, when ap-
propriate, weekly doxycycline prophylaxis.
Description of the Pathogen
There are more than 200 antigenically distinct
serovars or strains of leptospire classified into about
23 groups under the species Leptospira interrogans .
The distribution of serovars varies around the
world. The pathogenicity of serovars varies from
animal to animal and even between “identical”
serovars from different regions. 3 A newly recog-
nized species, L fainei , may also affect humans. A
nonpathogenic species, L biflexa , also exists. Ad-
vances in molecular genetics are leading to a vari-
ety of new classification schemes that do not relate
to traditional serological groupings.
Leptospires are obligate aerobes. They are flex-
ible, tightly coiled, helicoidal rods with one or both
ends usually hooked. Due to its thinness and mo-
tility, darkfield microscopy is necessary for optimal
visualization even with staining.
Geographic Distribution
Leptospirosis can be found in almost every coun-
try, though the distribution within a country reflects
the variations in host-animal populations and the
environment. 3 Cases have been recognized in vir-
tually all states in the United States, though most
reports are from Hawaii and the less-arid southern
states. 5
As was clearly evident with US troops training
in Panama, risk may increase significantly in the
rainy season. Rains or flooding can enhance the
flushing of subsurface leptospires into surface wa-
ters and draw shedding rodents and other animals
to swampy areas. 8 Urban flooding following hurri-
canes and other heavy rains is also associated with
increased risk. The seasonality of reported cases
may also reflect the cyclic nature of human agri-
cultural or recreational activity. Though persons
in arid areas tend to be at lesser risk of leptospiro-
sis, significant transmission can occur under the
right environmental conditions, carrier prevalence,
Epidemiology
Transmission
Leptospires can live free or in association with
human and animal hosts. Animals that survive the
acute infection may shed the organisms in their
urine for years. In a 1982 survey of 139 small ani-
mals trapped at the Jungle Operations Training
939
Military Preventive Medicine: Mobilization and Deployment, Volume 2
and human behaviors. For example, the concen-
tration of shedding animals and people around
scarce water holes or oases may create opportu-
nities for transmission.
Pathogenesis and Clinical Findings
The underlying pathologic effect of acute lep-
tospirosis resembles a vasculitis with damage to the
endothelial lining of capillaries coupled with
hepatitic and renal tubular dysfunction. 10 Histori-
cally most leptospirosis deaths have been due to
renal failure, but dialysis has reduced the fatality
of this factor. Cardiac effects, to include myocardi-
tis and arrhythmias, are now the leading cause of
death in leptospirosis. Hemorrhagic manifestations
are also common in severe cases. Jaundice is a ma-
jor feature of severe leptospirosis and appears to
reflect hepatic cell dysfunction more than hemoly-
sis. Survivors generally have no lasting liver or re-
nal dysfunction. Repeated infections with other
serovars can occur. Intrauterine infections can cause
fetal loss, premature labor, and congenital infection.
The incubation period for leptospirosis is typi-
cally 7 to 12 days (range: 2 to 26 days). Very short
incubations have been seen in laboratory exposures.
Although about 90% of recognized cases present as
a mild, self-limited febrile illness, in a prospective
serosurvey of soldiers that identified 24 infected
persons, only one denied any symptomatology. 2 It
is quite possible that if all cases were ascertained,
even more than 90% would be recognized as mild.
Mild, anicteric patients often present with the
sudden onset of fever that peaks at 38°C to 40°C.
Other complaints may include headache, chills,
back and joint pain, neck stiffness, and intense
myalgia. Even lightly touching the skin over the
thighs, calves, and lumbosacral muscles may elicit
notable pain. A commonly described finding dur-
Incidence
The incidence of leptospirosis is grossly under-
reported because the clinical presentation is often
that of a nonspecific influenza-like illness. Most
cases are not specifically diagnosed or are misdiag-
nosed as a more common febrile infection such as
dengue. On occasion this can be a fatal mistake.
Clinical awareness of the patient’s epidemiologic
history and a high index of suspicion are essential
to making this diagnosis and instituting timely, ef-
fective therapy.
Leptospirosis occurs both sporatically and in
common-source outbreaks. Probably the highest
incidence documented has been in US forces train-
ing in Panama. Between 1977 and 1982, close surveil-
lance was conducted on seven US Army units at-
tending the 3-week course at the Jungle Operations
Training Center during the fall rainy season. This
surveillance yielded 91 confirmed and probable
cases, for an annualized incidence estimate of 41,000
per 100,000 person years (Takafuji ET. 1984. Unpub-
lished data) (Figure 36-1). Since these troops in
training did not have daily exposure, the real risk
was probably even higher. Clearly these attack rates
indicate that an intense operational exposure to
contaminated environments can have a major impact
on not only individual health but also unit capabil-
ity and mission accomplishment.
Fig. 36-1 . A typical occupational exposure: soldiers in
the mud at the Jungle Operations Training Center,
Panama.
US Army photograph.
Fig. 36-2 . Conjunctival suffusion in a soldier with lep-
tospirosis Photograph: Courtesy of Colonel Ernest
Takafuji, Medical Corps, US Army.
940
452366238.002.png 452366238.003.png
Diseases Transmitted Primarily from Animals to Humans
ing the first 3 days of illness is conjunctival suffu-
sion, a dilation of the conjunctival vessels without
associated signs of inflammation (Figure 36-2). Gen-
eralized abdominal pain is sometimes noted and
may suggest a “surgical abdomen” or enteric fever.
Nausea, vomiting, diarrhea, and constipation may
also be reported. Skin manifestations of mild lep-
tospirosis can include a variety of rashes, mainly
but not exclusively on the trunk. Meningeal irritation,
photophobia, and a variable degree of physiological
dysfunction may also noted in mild disease.
Although often not noted by clinicians, classi-
cally leptospirosis is described as having an initial
leptospiremic phase followed after a 1- to 5-day
fairly asymptomatic period by a secondary lepto-
spiuric phase. The leptospiremic phase typically
lasts 4 to 7 days and ends about the time antibodies
appear. During the leptospiruric phase, fever re-
turns and may be associated with signs of aseptic
meningitis 10 (Figure 36-3). The severity of the men-
ingitis is variable. The second phase may last 4 to
30 days or longer. In a review of 150 cases in ser-
vice members serving in Vietnam, however, only
48% of cases were noted to have this second phase,
which usually lasted only 1 day. 1
In that minority of cases with severe leptospiro-
sis, the initial fever and generalized abnormalities
can progress to manifest jaundice, azotemia, hem-
orrhage, anemia, shock, and altered mental status.
As the disease progresses into the second week,
hemorrhagic manifestations may be noted in the
skin, conjunctiva, and sputum. 10 Deaths due to adre-
nal hemorrhage have been noted but are rare. Renal
failure, acute respiratory distress syndrome, con-
gestive heart failure, and arrhythmias are additional
manifestations of severe leptospirosis. Hemorrhagic
pneumonitis has been a significant manifestation
in infections acquired in Korea, other Far Eastern
locales, and Nicaragua. Mild proteinuria is a no-
table laboratory finding. Vitamin K can correct the
prothrombin deficiency that is sometimes seen.
Other common laboratory findings include elevated
creatinine phosphokinase and amalyse levels, neu-
trophilia, and thrombocytopenia. During the sec-
ondary phase, the cerebrospinal fluid may show a
pleocytosis. A variety of chest roentgenogram ab-
normalities are common and may include pulmo-
nary opacities, pleural effusion, and evidence of
myositis or pericardial effusion. Electrocardio-
graphic abnormalities are also noted.
Published case fatality rates vary widely, prob-
ably reflecting geographic variation in serovars and
in the low proportion of mild cases that are specifi-
cally diagnosed. Overall, the true case fatality is
ANICTERIC LEPTOSPIROSIS
ICTERIC LEPTOSPIROSIS
(WEIL'S SYNDROME)
First Phase
3–7 days
(Leptospiremic)
Second Phase
0 days – 1 month
(Leptospiruric or Immune)
First Phase
3–7 days
(Leptospiremic)
Second Phase
10 – 30 days
(Leptospiruric or Immune)
Myalgia
Headache
Abdominal Pain
Vomiting
Conjunctival Suffusion
Fever
50+% of cases asymptomatic
Meningitis
Uveitis
Rash
Fever
Jaundice
Hemorrhage
Renal Failure
Myocarditis
Blood
Blood
CSF
CSF
Urine
Urine
Fig. 36-3 . The clinical course of leptospirosis
Reprinted with permission from: Feigin Rd, Anderson DC. Leptospirosis. In: Feigin RD, Cherry JD, eds.
Textbook of Pediatric Infectious Disease . Vol 2. Philadelphia: W.B. Saunders; 1998: 1534.
941
452366238.004.png 452366238.001.png
Zgłoś jeśli naruszono regulamin